Methylhippuric acid

CAS No. 1205-08-9

Methylhippuric acid( Methyl hippurate )

Catalog No. M29495 CAS No. 1205-08-9

Methylhippuric acid is a xylene exposure biomarker in human urine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG 642 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methylhippuric acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Methylhippuric acid is a xylene exposure biomarker in human urine.
  • Description
    Methylhippuric acid is a xylene exposure biomarker in human urine.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Methyl hippurate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1205-08-9
  • Formula Weight
    193.202
  • Molecular Formula
    C10H11NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC(=O)CNC(=O)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pilocarpine

    Pilocarpine has been used to treat glaucoma, ocular hypertension and xerostomia. Pilocarpine can induce seizures.

  • BC-1471

    STAMBP-IN-1 is a small-molecule inhibitor of STAMBP deubiquitinase, and interrupts STAMBP-Ub-NALP7 interaction. STAMBP-IN-1 decreases protein level of its inflammasome substrate NALP7 and suppresses IL-1b release after Toll-like receptor (TLR) agonism. STAMBP-IN-1 inhibits the activity of STAMBP to cleave recombinant di-Ub with an IC50 value of 0.33 mM

  • E64FC26

    E64FC26 is a potent protein disulfide isomerase (PDI) family pan-inhibitor with antitumor activity, inhibits PDIA1, PDIA3, PDIA4, TXNDC5 and PDIA6, and can be used in the study of multiple myeloma and pancreatic cancer.